|
| |
| | | 58351 | | 19.11.2008 | | Janssen-Cilag AG | | | | | | | 01.08.2023 | | | | | | 01.01.30. | | 05.09.2023 | | 01.01.30. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Jurnista 8 mg | Retardtabletten | Delayed release tablets (Hydromorphon Hydrochloride 8 mg) | N02AA03 | CI | | 02 | Jurnista 16 mg | Retardtabletten | Delayed release tablets (Hydromorphon Hydrochloride 16 mg) | N02AA03 | CI | | 03 | Jurnista 32 mg | Retardtabletten | Delayed release tablets (Hydromorphon Hydrochloride 32 mg) | N02AA03 | CI | | 05 | Jurnista 4 mg | Retardtabletten | Delayed release tablets (Hydromorphon Hydrochloride 4 mg) | N02AA03 | CI |
|
|
|
